DERM vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 05, 2026

DERM

50.3
AI Score
VS
CRON Wins

CRON

61.5
AI Score

Investment Advisor Scores

DERM

50score
Recommendation
HOLD

CRON

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DERM CRON Winner
Revenue 15.96M 45.21M CRON
Net Income -2.23M 13.75M CRON
Net Margin -14.0% 30.4% CRON
Operating Income -1.49M -1.83M DERM
ROE -7.2% 1.3% CRON
ROA -2.4% 1.2% CRON
Total Assets 91.53M 1.17B CRON
Cash 27.22M 821.86M CRON
Current Ratio 1.72 21.87 CRON

Relative Price Performance (Last 90 Days)

DERM 1M: -4.5% · 3M: +24.3% CRON 1M: +0.4% · 3M: +4.9%

Current Technical Phase

DERM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $6.44

CRON

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.9 · Price: $2.76

Fundamentals Snapshot

Metric DERM CRON
Market Cap
Forward P/E 6.2 19.5
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.2% 0.4%
Gross Margin 0.7% 0.4%
Operating Margin -0.1% 0.0%
EPS -0.37 0.00
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRON is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.